Endocrine-disrupting chemicals – yet another environmental factor associated with endometriosis?

Several of the endocrine-disrupting chemicals increase the risk of endometriosis according to this meta-analysis


Key Points Lay Summary

Urocortin: A biomarker deserving investigation for endometriosis patients

Urocortin may be a potentially useful tool for the classification of endometriosis regarding its correlation with the severity of the disease.


Key Points Lay Summary

The coelomic metaplasia hypothesis of endometriosis in MRKH cases

The development of endometriosis in patients with MRKH could be explained through implantation hypothesis from uterus/endometrium remnants and coelomic metaplasia hypothesis.


Key Points Lay Summary

ENDORECT scoring system to identify patients at risk for rectosigmoid endometriosis

ENDORECT: Can a pre-operative score effectively predict rectosigmoid involvement in patients with endometriosis?


Key Points Lay Summary

Endometriosis pathophysiology: research in genes updated

What are the promising genetic research methods in endometriosis ?


Key Points Lay Summary

Novel inhibitors of estrogen biosynthesis

Dr. Ferrero group suggest that the generation of inhibitors blocking the local estrogen biosynthesis is the future direction in endometriosis treatment


Key Points Lay Summary

Another Genetic Polymorphism That May Increase Risk of Endo

A single letter change in the gene encoding a protein that controls cell proliferation can significantly increase endometriosis risk, at least in Chinese women.


Key Points Lay Summary

Searching new biomarkers for endometriosis

The lack of a biomarker in endometriosis is due to the heterogeneous nature of this disease.


Key Points Lay Summary
‹ First  < 164165 166 >  Last ›